Barclays analyst Peter Lawson reiterated an Overweight rating and $100.00 price target on Nuvalent (NASDAQ: NUVL).The analyst comments "We initiated ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE